Ballou J E, Gies R A, Case A C, Haggard D L, Buschbom R L, Ryan J L
Health Phys. 1986 Dec;51(6):755-71. doi: 10.1097/00004032-198612000-00006.
Little information exists on the metabolism and potential health effects of 233U and 232U, high-specific-activity U isotopes associated with Th breeder systems. This paper describes the distribution and retention of the two isotopes following inhalation of uranyl nitrate, a simulated process solution. The lungs of rats exposed to 233UO2(NO3)2 and 232UO2(NO3)2 aerosols contained from 7 to 23% of the total amount of U retained in the rat after a 30-min inhalation exposure. Uranium was translocated rapidly from the lung and was retained mainly in skeleton, kidney and liver. Amounts equivalent to from one-quarter to one-half the initial lung burden (ILB) of U were excreted in urine the first day after inhalation. Radiation dose estimates based on 233U and 232U retention kinetics indicate that lung and skeleton would be the target organs for delayed radiation effects.
关于233U和232U(与钍增殖反应堆系统相关的高比活度铀同位素)的代谢及潜在健康影响的信息很少。本文描述了吸入硝酸铀酰(一种模拟工艺溶液)后这两种同位素的分布和滞留情况。在30分钟吸入暴露后,暴露于233UO2(NO3)2和232UO2(NO3)2气溶胶的大鼠肺部所含的铀占大鼠体内滞留铀总量的7%至23%。铀从肺部迅速转移,主要滞留在骨骼、肾脏和肝脏中。吸入后第一天,尿中排出的铀量相当于肺部初始负荷(ILB)的四分之一至二分之一。基于233U和232U滞留动力学的辐射剂量估计表明,肺和骨骼将是延迟辐射效应的靶器官。